Sorrento Therapeutics Inc. today announced an antibody discovery and development collaboration with The Scripps Research Institute La Jolla CA. Under the terms of the agreement Sorrento Therapeut ...
| Left ads(Maximum width:590px) |
Sorrento Therapeutics Inc. today announced an antibody discovery and development collaboration with The Scripps Research Institute La Jolla CA. Under the terms of the agreement Sorrento Therapeutics obtains an exclusive worldwide license to the Institute's novel technology based on quorum sensing for the prevention and treatment of Staphylococcus aureus ('Staph') infections including ...